-transparent.png){kind=logo}
Fluorocitrate is a specific inhibitor of aconitase activity (EC 4.2.1.3). It causes an inhibition of citric acid cycle reactions and consequently reduces the oxygen consumption, as well as the total volume of oxidative phosphorylations. Experiments using 3H-thymidine incorporation into mouse lymphosarcoma LS/BL cells proved that the in vitro blocking of citric acid cycle by fluorocitrate (3.6 and 7.2 mM) was accompanied by a decrease in DNA synthesis by 40 to 60 percent, as compared to control cells. A similar inhibitory effect upon DNA synthesis was also found in cells cultured in the abdominal cavity of host mice injected intraperitoneally with 5 mg./kg. of sodium fluoroacetate. Following the injection, fluorocitrate is formed in vivo by way of Peters' lethal synthesis.
L Novák, and
V Jurásková
January 1987,
Neoplasma,
L Novák, and
V Jurásková
December 1984,
Radiation research,
L Novák, and
V Jurásková
January 1984,
The British journal of cancer. Supplement,
L Novák, and
V Jurásková
January 1982,
Folia biologica,
L Novák, and
V Jurásková
January 1975,
Neoplasma,
L Novák, and
V Jurásková
January 1987,
Folia biologica,
L Novák, and
V Jurásková
January 1975,
Folia biologica,
L Novák, and
V Jurásková
September 1976,
Cancer research,
L Novák, and
V Jurásková
January 1954,
The Biochemical journal,
L Novák, and
V Jurásková
January 1981,
Folia biologica,
